These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27665382)

  • 1. Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features.
    Fitzpatrick AM; Stephenson ST; Brown MR; Nguyen K; Douglas S; Brown LAS
    J Allergy Clin Immunol Pract; 2017; 5(2):410-419.e4. PubMed ID: 27665382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach.
    Bossley CJ; Fleming L; Ullmann N; Gupta A; Adams A; Nagakumar P; Bush A; Saglani S
    J Allergy Clin Immunol; 2016 Aug; 138(2):413-420.e6. PubMed ID: 27061250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.
    Sousa AR; Marshall RP; Warnock LC; Bolton S; Hastie A; Symon F; Hargadon B; Marshall H; Richardson M; Brightling CE; Haldar P; Milone R; Chalk P; Williamson R; Panettieri R; Knowles R; Bleecker ER; Wardlaw AJ
    Clin Exp Allergy; 2017 Jul; 47(7):890-899. PubMed ID: 28493293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthma.
    Stephenson ST; Brown LA; Helms MN; Qu H; Brown SD; Brown MR; Fitzpatrick AM
    J Allergy Clin Immunol; 2015 Aug; 136(2):454-61.e9. PubMed ID: 25748343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.
    Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR
    Am J Respir Crit Care Med; 1996 Feb; 153(2):551-6. PubMed ID: 8564096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.
    Phipatanakul W; Mauger DT; Sorkness RL; Gaffin JM; Holguin F; Woodruff PG; Ly NP; Bacharier LB; Bhakta NR; Moore WC; Bleecker ER; Hastie AT; Meyers DA; Castro M; Fahy JV; Fitzpatrick AM; Gaston BM; Jarjour NN; Levy BD; Peters SP; Teague WG; Fajt M; Wenzel SE; Erzurum SC; Israel E;
    Am J Respir Crit Care Med; 2017 Jun; 195(11):1439-1448. PubMed ID: 27967215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response.
    Xiao C; Biagini Myers JM; Ji H; Metz K; Martin LJ; Lindsey M; He H; Powers R; Ulm A; Ruff B; Ericksen MB; Somineni HK; Simmons J; Strait RT; Kercsmar CM; Khurana Hershey GK
    J Allergy Clin Immunol; 2015 Oct; 136(4):923-31.e3. PubMed ID: 25910714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid.
    Gelb AF; Moridzadeh R; Singh DH; Fraser C; George SC
    J Allergy Clin Immunol; 2012 Jun; 129(6):1491-8. PubMed ID: 22560478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled nitric oxide after a single dose of intramuscular triamcinolone in children with difficult to control asthma.
    Panickar JR; Bhatnagar N; Grigg J
    Pediatr Pulmonol; 2007 Jul; 42(7):573-8. PubMed ID: 17526005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity Is Associated with Sustained Symptomatology and Unique Inflammatory Features in Children with Asthma.
    Fitzpatrick AM; Mutic AD; Mohammad AF; Stephenson ST; Grunwell JR
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):815-826.e2. PubMed ID: 34688962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma?
    Lex C; Jenkins G; Wilson NM; Zacharasiewicz A; Erin E; Hansel TT; Bush A; Payne DN
    Pediatr Pulmonol; 2007 Mar; 42(3):298-303. PubMed ID: 17262857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Utility of Noninvasive Type 2 Inflammatory Markers for Prediction of Severe Asthma Exacerbations in Children and Adolescents.
    Shah SP; Grunwell J; Shih J; Stephenson S; Fitzpatrick AM
    J Allergy Clin Immunol Pract; 2019; 7(8):2624-2633.e2. PubMed ID: 31100552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
    Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
    Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple prediction tool for inhaled corticosteroid response in asthmatic children.
    Wu YF; Su MW; Chiang BL; Yang YH; Tsai CH; Lee YL
    BMC Pulm Med; 2017 Dec; 17(1):176. PubMed ID: 29216859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic Variation in Response to IM Triamcinolone in Children With Severe Therapy-Resistant Asthma.
    Koo S; Gupta A; Fainardi V; Bossley C; Bush A; Saglani S; Fleming L
    Chest; 2016 Jan; 149(1):98-105. PubMed ID: 26378892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting asthma morbidity in children using proposed markers of Th2-type inflammation.
    Konradsen JR; Skantz E; Nordlund B; Lidegran M; James A; Ono J; Ohta S; Izuhara K; Dahlén SE; Alving K; Hedlin G
    Pediatr Allergy Immunol; 2015 Dec; 26(8):772-9. PubMed ID: 26266838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
    Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
    Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
    Stelmach I; Majak P; Jerzynska J; Stelmach W; Kuna P
    Pediatr Allergy Immunol; 2004 Aug; 15(4):359-64. PubMed ID: 15305946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study.
    Pham DD; Shin E; Lee JE; Lee JH; Song WJ; Kwon HS; Cho YS; Won S; Kim TB
    Lung; 2024 Aug; 202(4):449-457. PubMed ID: 38995391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.